Literature DB >> 24931957

Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis.

Serena Calandra1, Maria Chiara Gallo1, Alessandro Consolaro1, Angela Pistorio1, Bianca Lattanzi1, Francesca Bovis1, Valentina Muratore1, Riccardo De Marco1, Alberto Martini1, Angelo Ravelli2.   

Abstract

OBJECTIVE: To investigate the risk factors for chronic anterior uveitis in patients with juvenile idiopathic arthritis (JIA).
METHODS: The clinical charts of patients followed between January 1987 and December 2011 were reviewed to establish whether they had uveitis. Inclusion criteria were a diagnosis of JIA and a disease category of persistent oligoarthritis, extended oligoarthritis, rheumatoid factor-negative polyarthritis, psoriatic arthritis, or undifferentiated arthritis. Risk factors included sex, age at arthritis onset, disease category, and antinuclear antibody (ANA) status. The association of risk factors with occurrence of uveitis was evaluated by survival analysis, with first episode of uveitis as the event of interest, and Cox regression analysis.
RESULTS: Of a total of 1189 patients, 278 (23.4%) had uveitis a median of 1.1 years after onset of arthritis. There was no difference in the cumulative probability of developing uveitis between males and females and between patients belonging to different JIA categories, whereas uveitis was strongly associated with age at arthritis onset ≤ 3.5 years and positive ANA. Patients possessing the latter 2 factors in combination had a greater probability of having uveitis than patients who had either of them alone.
CONCLUSION: In our patients, the risk of uveitis was related to younger age at onset of arthritis and presence of ANA, but not to female sex and disease category. This finding suggests that the patients who require the most intensive ophthalmologic screening are those who have early-onset JIA and are ANA-positive, regardless of their sex or disease subtype.

Entities:  

Keywords:  IRIDOCYCLITIS; JUVENILE IDIOPATHIC ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS; RISK FACTORS; UVEITIS

Mesh:

Year:  2014        PMID: 24931957     DOI: 10.3899/jrheum.131494

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 2.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

Review 3.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 4.  Advances in biomarkers for paediatric rheumatic diseases.

Authors:  Alessandro Consolaro; Giulia C Varnier; Alberto Martini; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

5.  Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy.

Authors:  I Castagna; A M Roszkowska; F Alessandrello; G W Oliverio; G Tumminello; R Gallizzi; G Conti; P Aragona
Journal:  Int Ophthalmol       Date:  2019-10-04       Impact factor: 2.031

6.  Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

Authors:  Sara Verazza; Sergio Davì; Alessandro Consolaro; Francesca Bovis; Antonella Insalaco; Silvia Magni-Manzoni; Rebecca Nicolai; Denise Pires Marafon; Fabrizio De Benedetti; Valeria Gerloni; Irene Pontikaki; Francesca Rovelli; Rolando Cimaz; Achille Marino; Francesco Zulian; Giorgia Martini; Serena Pastore; Chiara Sandrin; Fabrizia Corona; Marta Torcoletti; Giovanni Conti; Claudia Fede; Patrizia Barone; Marco Cattalini; Elisabetta Cortis; Luciana Breda; Alma Nunzia Olivieri; Adele Civino; Rosanna Podda; Donato Rigante; Francesco La Torre; Gianfranco D'Angelo; Mauro Jorini; Romina Gallizzi; Maria Cristina Maggio; Rita Consolini; Alessandro De Fanti; Valentina Muratore; Maria Giannina Alpigiani; Nicolino Ruperto; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-12-20       Impact factor: 3.054

7.  Patient's experiences with the care for juvenile idiopathic arthritis across Europe.

Authors:  E H Pieter van Dijkhuizen; Tsipi Egert; Yona Egert; Wendy Costello; Casper Schoemaker; Marlous Fernhout; Mirjam Kepic; Alberto Martini; Silvia Scala; Ingrid Rotstein-Grein; Sebastiaan J Vastert; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2018-02-08       Impact factor: 3.054

8.  Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Authors:  Tamas Constantin; Ivan Foeldvari; Jordi Anton; Joke de Boer; Severine Czitrom-Guillaume; Clive Edelsten; Raz Gepstein; Arnd Heiligenhaus; Clarissa A Pilkington; Gabriele Simonini; Yosef Uziel; Sebastian J Vastert; Nico M Wulffraat; Anne-Mieke Haasnoot; Karoline Walscheid; Annamária Pálinkás; Reshma Pattani; Zoltán Györgyi; Richárd Kozma; Victor Boom; Andrea Ponyi; Angelo Ravelli; Athimalaipet V Ramanan
Journal:  Ann Rheum Dis       Date:  2018-03-28       Impact factor: 19.103

9.  Juvenile idiopathic arthritis-associated uveitis in the era of biological therapy: how the disease changed in more than 20 years of observation in a tertiary referral center in Rome (Italy).

Authors:  E Del Giudice; C Simio; A Scala; A Di Coste; G La Torre; L Spadea; R Lubrano; M Duse; M P Paroli
Journal:  Int Ophthalmol       Date:  2021-10-20       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.